IXC 0.00% 7.0¢ invex therapeutics ltd

Ann: Invex Granted Type C Meeting with FDA, page-100

  1. 335 Posts.
    lightbulb Created with Sketch. 147
    that’s very interesting.

    given that they’re projecting needing to do the trial on n=250 patients. I wonder if they’re covering that number between sites in the UK and the US, or whether they have to double that number to satisfy the FDA.

    given that the EMA only wants one trial, I would imagine invex would only run the ICP outcome in Europe only.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 6.3¢ $5.263K 76.69K

Buyers (Bids)

No. Vol. Price($)
1 38879 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.14pm 20/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.